Patient Expectations From Implantable Defibrillators to Prevent Death in Heart Failure
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Background Indications for implantable cardioverter-defibrillators (ICDs) in heart failure (HF) are expanding and may include more than 1 million patients. This study examined patient expectations from ICDs for primary prevention of sudden death in HF. Methods and Results Study participants (n = 105) had an EF <35% and symptomatic HF, without history of ventricular tachycardia/fibrillation or syncope. Subjects completed a written survey about perceived ICD benefits, survival expectations, and circumstances under which they might deactivate defibrillation. Mean age was 58, LVEF 21%, 40% were New York Heart Association Class III-IV, and 65% already had a primary prevention ICD. Most patients anticipated more than10 years survival despite symptomatic HF. Nearly 54% expected an ICD to save ≥50 lives per 100 during 5 years. ICD recipients expressed more confidence that the device would save their own lives compared with those without an ICD (P < .001). Despite understanding the ease of deactivation, 70% of ICD recipients indicated they would keep the ICD on even if dying of cancer, 55% even if having daily shocks, and none would inactivate defibrillation even if suffering constant dyspnea at rest. Conclusions HF patients anticipate long survival, overestimate survival benefits conferred by ICDs, and express reluctance to deactivate their devices even for end-stage disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043399 · Cited by 6,552
ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities
Epstein, A. E., DiMarco, J. P., Ellenbogen, K. A., Estes, N. A. M., Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.02.032 · Cited by 2,546
Self-citationWRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.167586 · Cited by 2,251
Self-citationProphylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction
Hohnloser, S. H., Kuck, K. H., Dorian, P., Roberts, R. S., Hampton, J. R., Hatala, R., Fain, E., Gent, M., & Connolly, S. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041489 · Cited by 1,519
Schron, E. B., Exner, D. V., Yao, Q., Jenkins, L. S., Steinberg, J. S., Cook, J. R., Kutalek, S. P., Friedman, P. L., Bubien, R. S., Page, R. L., et al. (2002) · Circulation · doi:10.1161/hc0502.103330 · Cited by 624
Management of Implantable Cardioverter Defibrillators in End-of-Life Care
Goldstein, N. E., Lampert, R., Bradley, E., Lynn, J., & Krumholz, H. M. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-11-200412070-00006 · Cited by 325
Quality of Life with Defibrillator Therapy or Amiodarone in Heart Failure
Mark, D. B., Anstrom, K. J., Sun, J. L., Clapp-Channing, N. E., Tsiatis, A. A., Davidson-Ray, L., Lee, K. L., & Bardy, G. H. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706719 · Cited by 260
Changing preferences for survival after hospitalization with advanced heart failure
Stevenson, L. W., Hellkamp, A. S., Leier, C. V., Sopko, G., Koelling, T., Warnica, J. W., Abraham, W. T., Kasper, E. K., Rogers, J. G., Califf, R. M., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.028 · Cited by 164
Self-citation
Research works printed but not linked: 44
- 2006, 2006 Comprehensive Heart Failure Practice Guideline, J Cardiac Failure, 12, e1, 10.1016/j.cardfail.2005.11.005 · DOI · Paper page
- Moss, 2002, Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction, N Engl J Med, 346, 877, 10.1056/NEJMoa013474 · DOI · Paper page
- Kadish, 2004, Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy, N Engl J Med, 350, 2151, 10.1056/NEJMoa033088 · DOI · Paper page
- Desai, 2004, Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials, JAMA, 292, 2874, 10.1001/jama.292.23.2874 · DOI · Paper page
- Rosamond, 2008, Heart disease and stroke statistics—2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Circulation, 117, e25, 10.1161/CIRCULATIONAHA.107.187998 · DOI · Paper page
- Kannel, 1988, Cardiac failure and sudden death in the Framingham Study, Am Heart J, 115, 869, 10.1016/0002-8703(88)90891-5 · DOI · Paper page
- Hammill, 2007, Review of the registry's first year, data collected, and future plans, Heart Rhythm, 4, 1260, 10.1016/j.hrthm.2007.07.021 · DOI
- Tung, 2008, A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death, J Am Coll Cardiol, 52, 1111, 10.1016/j.jacc.2008.05.058 · DOI · Paper page
- Setoguchi, 2007, Repeated hospitalizations predict mortality in the community population with heart failure, Am Heart J, 154, 260, 10.1016/j.ahj.2007.01.041 · DOI · Paper page
- Carson, 2005, Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial, J Am Coll Cardiol, 46, 2329, 10.1016/j.jacc.2005.09.016 · DOI · Paper page
- Sanders, 2005, Cost-effectiveness of implantable cardioverter-defibrillators, N Engl J Med, 353, 1471, 10.1056/NEJMsa051989 · DOI · Paper page
- Mark, 2006, Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT), Circulation, 114, 135, 10.1161/CIRCULATIONAHA.105.581884 · DOI · Paper page
- Ellenbogen, 2006, Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?, Circulation, 113, 776, 10.1161/CIRCULATIONAHA.105.561571 · DOI · Paper page
- Moss, 2004, Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator, Circulation, 110, 3760, 10.1161/01.CIR.0000150390.04704.B7 · DOI · Paper page
- Ahmad, 2000, Patients' attitudes toward implanted defibrillator shocks, Pacing Clin Electrophysiol, 23, 934, 10.1111/j.1540-8159.2000.tb00877.x · DOI · Paper page
- Passman, 2007, Implantable cardioverter defibrillators and quality of life: results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study, Arch Intern Med, 167, 2226, 10.1001/archinte.167.20.2226 · DOI · Paper page
- Daubert, 2008, Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact, J Am Coll Cardiol, 51, 1357, 10.1016/j.jacc.2007.09.073 · DOI · Paper page
- Sola, 2005, Implantable cardioverter-defibrillators, induced anxiety, and quality of life, Mayo Clin Proc, 80, 232, 10.4065/80.2.232 · DOI
- Dunbar, 1993, Internal cardioverter defibrillator device discharge: experiences of patients and family members, Heart Lung, 22, 494
- Prudente, 2006, Psychological indices and phantom shocks in patients with ICD, J Interv Card Electrophysiol, 15, 185, 10.1007/s10840-006-9010-z · DOI
- Thomas, 2006, Quality of life and psychological status of patients with implantable cardioverter defibrillators, Am J Crit Care, 15, 389, 10.4037/ajcc2006.15.4.389 · DOI · Paper page
- Epstein, 2008, Circulation, 117, 2820, 10.1161/CIRCUALTIONAHA.108.189741 · DOI · Paper page
- Torrance, 1987, Utility approach to measuring health-related quality of life, J Chronic Dis, 40, 593, 10.1016/0021-9681(87)90019-1 · DOI · Paper page
- Goldenberg, 2006, Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II, Circulation, 113, 2810, 10.1161/CIRCULATIONAHA.105.577262 · DOI · Paper page
- Moss, 2004, Temporal aspects of improved survival with the implanted defibrillator (MADIT-II), Am J Cardiol, 94, 312, 10.1016/j.amjcard.2004.04.025 · DOI
- Stevenson, 2006, Cost-effectiveness of ICDs, N Engl J Med, 354, 205, 10.1056/NEJMc052976 · doi:10.1056/nejmc052976
- Zwanziger, 2006, The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II, J Am Coll Cardiol, 47, 2310, 10.1016/j.jacc.2006.03.032 · DOI · Paper page
- 1997, A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators, N Engl J Med, 337, 1576, 10.1056/NEJM199711273372202 · DOI · Paper page
- Goldenberg, 2008, Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction, J Am Coll Cardiol, 51, 288, 10.1016/j.jacc.2007.08.058 · DOI · Paper page
- Zareba, 2005, Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population), American J Cardiol, 95, 1487, 10.1016/j.amjcard.2005.02.021 · DOI
- Mozaffarian, 2007, Prediction of mode of death in heart failure: the Seattle Heart Failure Model, Circulation, 116, 392, 10.1161/CIRCULATIONAHA.106.687103 · DOI · Paper page
- Teuteberg, 2006, Characteristics of patients who die with heart failure and a low ejection fraction in the new millennium, J Cardiac Failure, 12, 47, 10.1016/j.cardfail.2005.08.001 · DOI
- Sears, 2002, Quality of life and psychological functioning of ICD patients, Heart (Br Cardiac Soc), 87, 488, 10.1136/heart.87.5.488 · DOI · Paper page
- Lewis, 2006, Withdrawing implantable defibrillator shock therapy in terminally ill patients, Am J Med, 119, 892, 10.1016/j.amjmed.2006.01.017 · DOI
- Berger, 2005, The ethics of deactivating implanted cardioverter defibrillators, Ann Intern Med, 142, 631, 10.7326/0003-4819-142-8-200504190-00012 · DOI · Paper page
- Mueller, 2003, Ethical analysis of withdrawal of pacemaker or implantable cardioverter-defibrillator support at the end of life, Mayo Clin Proc, 78, 959, 10.1016/S0025-6196(11)63143-1 · doi:10.1016/s0025-6196(11)63143-1
- Stevenson, 2006, Selecting patients for discussion of the ICD as primary prevention for sudden death in heart failure, J Cardiac Failure, 12, 407, 10.1016/j.cardfail.2006.06.001 · DOI
- Politi, 2007, Communicating the uncertainty of harms and benefits of medical interventions, Med Decis Making, 27, 681, 10.1177/0272989X07307270 · DOI · Paper page
- Allen, 2008, Discordance between patient-predicted and model-predicted life expectancy among ambulatory patients with heart failure, JAMA, 299, 2533, 10.1001/jama.299.21.2533 · DOI · Paper page
- Lewis, 2001, Preferences for quality of life or survival expressed by patients with heart failure, J Heart Lung Transplant, 20, 1016, 10.1016/S1053-2498(01)00298-4 · DOI · Paper page
- Yancy, 2008, Predicting life expectancy in heart failure, JAMA, 299, 2566, 10.1001/jama.299.21.2566 · DOI
- Poole, 2008, Prognostic importance of defibrillator shocks in patients with heart failure, New Engl J Med, 359, 1009, 10.1056/NEJMoa071098 · DOI · Paper page
- van der Weijden, 2008, Koelewijn-van Loon MS. Primary care patients' recognition of their own risk for cardiovascular disease: implications for risk communication in practice, Curr Opin Cardiol, 23, 471, 10.1097/HCO.0b013e32830b35f6 · DOI
- Goodyear-Smith, 2008, Patients prefer pictures to numbers to express cardiovascular benefit from treatment, Ann Family Med, 6, 213, 10.1370/afm.795 · DOI
Cited by
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs104 · Cited by 6,879
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.592 · Cited by 5,866
Metadata
- Authors
- Stewart, G. C., Weintraub, J. R., Pratibhu, P. P., Semigran, M. J., Camuso, J. M., Brooks, K., Tsang, S. W., Anello, M. S., Nguyen, V. T., Lewis, E. F., Nohria, A., Desai, A. S., Givertz, M. M., & Stevenson, L. W.
- Venue
- Journal of Cardiac Failure
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 16
- Issue
- 2
- Pages
- 106-113
- ISSN
- 1071-9164 (ISSN-L)
- OpenAlex
- W1984358938
- Cited by
- 130
- References
- 8
- FWCI
- 5.34
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Patient Expectations From Implantable Defibrillators to Prevent Death in Heart Failure. https://app.cochat.ai/papers/10.1016/j.cardfail.2009.09.003
- The paper
- Stewart, G. C., Weintraub, J. R., Pratibhu, P. P., Semigran, M. J., Camuso, J. M., Brooks, K., Tsang, S. W., Anello, M. S., Nguyen, V. T., Lewis, E. F., Nohria, A., Desai, A. S., Givertz, M. M., & Stevenson, L. W. (2010). Patient Expectations From Implantable Defibrillators to Prevent Death in Heart Failure. Journal of Cardiac Failure. https://doi.org/10.1016/j.cardfail.2009.09.003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.